Sponsor:
Alcon Research
Code:
NCT05769153
Conditions
Neovascular Age-related Macular Degeneration (nAMD)
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
AR-14034 SR implant lower dose
AR-14034 SR implant higher dose
AR-14034 SR implant
Aflibercept Injection
Sham procedure
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-05-15. This information was provided to ClinicalTrials.gov by Alcon Research on 2026-01-06.